Schrodinger (SDGR) Stock Forecast: StockMap's 2-Week Call
SDGR stock forecast: StockMap's model makes no two-week call on Schrodinger after the Nov 13 close: its evidence is split, 1 reasons for and 14 against. Too few two-week windows graded to judge yet.
Schrodinger last closed at $29.53, -4.28% on the session.
Against the IVW growth benchmark the position is -3.37% over the forecast window.
Schrodinger's market cap is $2.22B as of November 13, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 0 (too close to call).
Where SDGR sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 1 bullish and 14 bearish.
Agreement across those insights is 93%.
6 daily calls for SDGR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Schrodinger in the 28th percentile on return on equity, where 100 is best.
Schrodinger is classified under Health Care / Health Care Technology.
StockMap tracks Schrodinger as the 5th largest of the 21 companies it covers in the Health Care Technology industry, part of the Health Care sector.
Across that group the current two-week reads are 14 Neutral, 3 Strong Underperform, 2 Moderate Outperform and 2 Moderate Underperform.
On that composite Schrodinger ranks 12th of 21 in the group, against a group median of +0.01.